Results 251 to 260 of about 711,573 (395)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.

open access: yesArthritis & Rheumatism, 1993
M. Elliott   +10 more
semanticscholar   +1 more source

Multiomics Analyses Reveal an Essential Role of Tryptophan in Treatment of csDMARDs in Rheumatoid Arthritis

open access: yesAdvanced Science, EarlyView.
Rheumatoid arthritis is a disease characterized by joint inflammation. Approximately 50% of patients show insufficient response to traditional synthetic disease‐modifying antirheumatic drugs. This study aims to elucidate differential molecular profiles of the mechanisms underlying drug responses through multi‐omics strategy.
Congcong Jian   +26 more
wiley   +1 more source

Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo.

open access: yesProceedings of the National Academy of Sciences of the United States of America, 1992
K. Zee   +5 more
semanticscholar   +1 more source

Gene sequence of porcine tumor necrosis factor alpha

open access: yesNucleic Acids Research, 1990
Roman T. Drews   +3 more
openaire   +4 more sources

Systematic Targeting of GD2‐Positive Neuroblastoma Tumors With a Photooncolytic Phage Nanovector Platform

open access: yesAdvanced Science, EarlyView.
A tumor‐penetrating photooncolytic phage is developed for selectively targeting and delivering photosensitizers to GD2‐positive Neuroblastoma cells. Upon light activation, it precisely induces oncolysis of GD2‐positive cells with no effect on GD2‐negative ones.
Suleman Khan Zadran   +25 more
wiley   +1 more source

Tumor necrosis factor-alpha expression in ischemic neurons.

open access: yesStroke, 1994
T. Liu   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy